Dermatology has three revenue lanes: medical, surgical, and pathology. Each has its own rules. Miss a modifier 25 on same-day biopsy and E/M and you lose both. We code them tight.
We see the same patterns across dermatology groups. The leaks are specific, recurring, and fixable with coding discipline and payer-aware claim construction.
Not a complete list. A representative slice of the codes that drive revenue and denials for dermatology practices.
| Code | Description | Profile |
|---|---|---|
| 11102 | Tangential biopsy, single lesion | High volume |
| 11104 | Punch biopsy, single lesion | Modifier-sensitive |
| 11400 series | Excision, benign lesion | Denial-prone |
| 11600 series | Excision, malignant lesion | High volume |
| 17311 | Mohs surgery, first stage | Modifier-sensitive |
| 17312 | Mohs, each additional stage | Denial-prone |
| 88305 | Surgical pathology, level IV | High volume |
Modifier 25 applied on same-day E/M plus procedure when documentation supports separately identifiable service. Excision size measured pre-excision (not specimen size). Pathology billed by the reading physician or in-house lab as appropriate.
Pattern we see. Modifier 25 denied for insufficient separate documentation, excision size disputed (specimen vs lesion plus margins), and cosmetic procedure billed to insurance without prior auth or medical necessity.
How we fix it. Every denial is logged against its CARC/RARC code and routed to a coder who owns the appeal. We rebuild the claim with the documentation the payer is actually asking for, not a generic reconsideration letter. Recovery rate on appealable dermatology denials averages above 60 percent.
A written 30-day diagnostic. Dollar figures against every finding. No obligation.